Alfavision Overseas (India) Limited (BOM:531156)
8.27
+0.03 (0.36%)
At close: Jun 19, 2026
BOM:531156 Market Cap
BOM:531156 has a market cap or net worth of 260.72 million as of June 18, 2026. Its market cap has decreased by -29.38% in one year.
Market Cap
260.72M
Enterprise Value
1.62B
Revenue
19.91M
Ranking
n/a
PE Ratio
206.75
Stock Price
8.27
Market Cap Chart
Since October 21, 2004, BOM:531156's market cap has increased from 14.19M to 260.72M, an increase of 1,737.78%. That is a compound annual growth rate of 14.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 260.72M | 38.99% |
| Dec 31, 2025 | 187.58M | -57.19% |
| Dec 31, 2024 | 438.21M | -22.95% |
| Dec 29, 2023 | 568.73M | 43.63% |
| Dec 30, 2022 | 395.97M | 1.01% |
| Dec 31, 2021 | 392.03M | 328.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.52B |
| Krebs Biochemicals & Industries | 1.42B |
| Smruthi Organics | 1.35B |
| Tyche Industries | 1.31B |
| Bacil Pharma | 583.45M |
| Vasundhara Rasayans | 539.98M |
| Crestchem | 428.25M |
| Venmax Drugs and Pharmaceuticals | 233.74M |